Question Bank › Operator fluency on fresh ground

Operator fluency on fresh ground

Operator fluency on fresh ground: management answers probing questions about a new driver with unhesitating operational

Calls Tested
499
Answered YES
40
Hit Rate
8%
rare by design

Pediatrix Medical Group, Inc. (MD) — this company's answers

NO on the Q3 2021 call 2021-10-28 B
The model's full reasoning — Q3 2021 call → NOWe need to determine if the transcript shows the dynamic described. The question asks about a "recently emerged positive element of the business" whose meaningful contribution began only within roughly the last few quarters. Analysts probe it, and management responds with unhesitating, granular operational command, answering follow-ups with specific present-tense working detail, while conveying that the element's contribution is still early. Looking at the transcript, the recently emerged element could be the Brave Care investment and the plan to open pediatric clinics. That was announced recently. Analysts ask about it: "On the Brave Care and the rollout of pediatric urgent care centers, can you comment a little bit on how much upfront start-up costs there are associated with that and then time to breakeven, time to mature margins on those clinics..." Management responds: "Well, if you think about the opening of the clinic, say, if you have roughly a couple of million dollar start-up costs, including early losses and then you have a strong return on that investment. It's a very high return on investment vehicle for us because of the overhead structure that we have in place and the relationships that we already have. So I think it fits with what we do, probably wouldn't recommend it to others. We will detail this as we go forward. But I think what you should expect is a clustered rollout in cities where we are that will minimize the additional overhead that's required to do this. As I've said, now importantly, we have the people to do it, the systems to do it and the relationships in our overall business. So we think it's going to be a very strong return vehicle, not a sideline to what we do." That is a response to a single question. The question asks for "across at least two exchanges" - meaning there should be follow-up questions and answers. In the transcript, after that answer, the analyst asks another question about capital structure and share repurchases, not about Brave Care. So there is only one exchange about Brave Care. The question says "across at least two exchanges" - so we need at least two exchanges on that element. Here we have only one. Also, the response is somewhat general: talks about start-up costs, return on investment, clustered rollout, but not specific operational detail like how many clinics, staffing, scheduling, etc.

← Back to the full MD analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when analysts probe a RECENTLY EMERGED positive element of the business — something whose meaningful contribution began only within roughly the last few quarters — does management respond with UNHESITATING, GRANULAR OPERATIONAL COMMAND: answering follow-up questions about that new element with specific, present-tense working detail (how it is actually being produced, delivered, staffed, scheduled, priced, or scaled; which kinds of counterparties are taking it and how they behave; what the company is doing this month and next to serve it) of the kind only operators deep inside a functioning activity could supply — while conveying that the element's contribution to the reported results is still early? Answer YES when the transcript shows this ONE dynamic, in whatever form fits the business: (1) the probed element is REAL AND CURRENT — actually transacting now, not a plan or pipeline; (2) it is YOUNG — new to meaningful contribution within recent quarters, per management's own framing; (3) management's answers across at least two exchanges ADD specific operational substance beyond the prepared remarks, without deflection, hedging into generalities, or retreat to talking points; and (4) management conveys, directly or plainly in substance, that most of the element's effect lies ahead of the reported numbers. Answer NO if the probed strength concerns the company's long-established core rather than something recently emerged. NO if management's answers repeat prepared points, answer specifics with generalities, or lean on vision and market size. NO if the added detail concerns only financial housekeeping (guidance arithmetic, tax, share count). NO if the element is already mature and substantially in the results. NO if the granular engagement occurs in only a single exchange. NO if the call lacks a substantive question-and-answer session. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
MCD McDonald's Corporation Q2 2024 2024-07-29 D
HCKT The Hackett Group, Inc. Q1 2024 2024-05-08 C
CTRA Coterra Energy Inc. Q1 2024 2024-05-03 A
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
WGO Winnebago Industries, Inc. Q1 2023 2022-12-16 D
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
ALHC Alignment Healthcare, Inc. Q3 2021 2021-11-06 B+
FFWM First Foundation Inc. Q3 2021 2021-10-26 B
KNDI Kandi Technologies Group, Inc. Q2 2021 2021-08-09 F
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
AMGN Amgen Inc. Q3 2018 2018-10-30 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
HLX Helix Energy Solutions Group, Inc. Q1 2018 2018-04-24 B+
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
FI Fiserv, Inc. Q4 2017 2018-02-27 C
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
GNTX Gentex Corporation Q3 2017 2017-10-20 B
BIIB Biogen Inc. Q2 2017 2017-07-25 B
AEHR Aehr Test Systems Q2 2017 2017-01-05 F
NDSN Nordson Corporation Q3 2016 2016-08-23 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
ENLC EnLink Midstream, LLC Q4 2015 2016-02-17 C+

How the model reasoned

IRT · Q2 2018 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it. YES The transcript shows management providing unhesitating, granular operational detail on the value-add program—a recently emerged positive element whose meaningful contribution began within the last few quarters—as probed by analysts like John Massocca and Craig Kucera. They discuss specifics such as NOI growth from phase 1 rehabs in 4Q 18 (14-15% range), phase 2 as a slight drag, $4.
LTRX · Q3 2024 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.
NICE · Q4 2023 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.

More from the question bank

Demand has broadened across independent fronNew chapter with early proofSkeptical premise dismantled with receiptsProfit machinery upgraded while volume stillExternal validators convergingThe bottleneck is inside and being paid awayAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.